{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-003118","form_type":"8-K","ticker":"ENTA","cik":"0001177648","company_name":"ENANTA PHARMACEUTICALS INC","filed_at":"2022-03-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.592907+00:00","generated_at":"2026-06-27T00:39:16.178688+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Enanta stockholders approve all proposals at 2022 annual meeting","bullets":["Elected Mark Foletta (16,269,503 votes for) and Lesley Russell (16,081,968 votes for) as Class III directors.","Approved amendment to 2019 Equity Incentive Plan, increasing reserved shares by 1,050,000.","Advisory say-on-pay proposal passed with 16,369,060 votes for, 933,286 against.","Ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2022 with 18,378,176 votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-003118","json":"https://secwatch.observer/filing/0000950170-22-003118.json","markdown":"https://secwatch.observer/filing/0000950170-22-003118.md","text":"https://secwatch.observer/filing/0000950170-22-003118.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1177648/000095017022003118/0000950170-22-003118-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1177648/000095017022003118/enta-20220303.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T00:39:16.178688+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}